Mithra Pharmaceuticals SA logo

Mithra Pharmaceuticals SA

EBR:MITRA.BR

Overview | Financials
Company Name Mithra Pharmaceuticals SA
Symbol MITRA.BR
Currency EUR
Price 0.216
Market Cap 14,927,414
Dividend Yield 0%
52-week-range 0.201 - 1.51
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. David Horn Solomon M.D.
Website https://www.mithra.com

An error occurred while fetching data.

About Mithra Pharmaceuticals SA

Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Europe and internationally. Its development candidates include Estelle, which has completed phase III clinical trial, which is a combined oral contraceptive; Donesta, which is in phase III clinical trial for estetrol-based

Related Stocks

Cegedim SA logo

Cegedim SA

CGM.PA

11.3 EUR

Guerbet SA logo

Guerbet SA

GBT.PA

29.7 EUR

ABIVAX Société Anonyme logo

ABIVAX Société Anonyme

ABVX.PA

9.45 EUR

Inventiva S.A. logo

Inventiva S.A.

IVA.PA

2.45 EUR

Bastide Le Confort Médical SA logo

Bastide Le Confort Médical SA

BLC.PA

17.68 EUR

LNA Santé SA logo

LNA Santé SA

LNA.PA

25.55 EUR

Prim, S.A. logo

Prim, S.A.

PRM.MC

9.7 EUR

Hyloris Pharmaceuticals SA logo

Hyloris Pharmaceuticals SA

HYL.BR

4.52 EUR

Laboratorio Reig Jofre, S.A. logo

Laboratorio Reig Jofre, S.A.

RJF.MC

2.87 EUR

Eurobio Scientific Société anonyme logo

Eurobio Scientific Société anonyme

ALERS.PA

25.75 EUR

Financials

Numbers are in millions USD

Numbers are in millions USD